Diabetes treatment doubles skin cancer drug's effectiveness
Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.
Apr 2, 2012
0
1